With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- Kim Kardashian : who were her first two husbands ? May 29, 2020
- After their fights, Kanye West promised to help Taylor Swift with her music. Sep 19, 2020
- Margot Robbie recently discovered the definition of sexual harassment Nov 23, 2022
- LFI: Clémentine Autain and François Ruffin criticize the lack of internal democracy among the Insoumis Dec 12, 2022
- Nayarit. Civil Protection declared on alert for Hurricane Nora Aug 29, 2021
- ‘A poisonous work environment’: Staff accused of sexual harassment and drug abuse in a lawsuit against Kenny’s office Oct 27, 2021
- Few people know about the Bonus Terme: it is not linked to the family unit or the ISEE and can be requested by all residents in Aug 29, 2021